IL157594A0 - Carbamate compounds for use in preventing or treating anxiety disorders - Google Patents
Carbamate compounds for use in preventing or treating anxiety disordersInfo
- Publication number
- IL157594A0 IL157594A0 IL15759402A IL15759402A IL157594A0 IL 157594 A0 IL157594 A0 IL 157594A0 IL 15759402 A IL15759402 A IL 15759402A IL 15759402 A IL15759402 A IL 15759402A IL 157594 A0 IL157594 A0 IL 157594A0
- Authority
- IL
- Israel
- Prior art keywords
- group
- preventing
- anxiety disorders
- treating anxiety
- phenyl
- Prior art date
Links
- 208000019901 Anxiety disease Diseases 0.000 title abstract 2
- 150000004657 carbamic acid derivatives Chemical class 0.000 title 1
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 3
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 abstract 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 abstract 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 abstract 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 abstract 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 abstract 1
- 229910052794 bromium Inorganic materials 0.000 abstract 1
- 229910052801 chlorine Inorganic materials 0.000 abstract 1
- 239000000460 chlorine Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 229910052731 fluorine Inorganic materials 0.000 abstract 1
- 239000011737 fluorine Substances 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 150000002367 halogens Chemical group 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 229910052740 iodine Inorganic materials 0.000 abstract 1
- 239000011630 iodine Substances 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Anesthesiology (AREA)
- Psychiatry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US27168901P | 2001-02-27 | 2001-02-27 | |
| PCT/US2002/005423 WO2002067923A1 (en) | 2001-02-27 | 2002-02-21 | Carbamate compounds for use in preventing or treating anxiety disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL157594A0 true IL157594A0 (en) | 2004-03-28 |
Family
ID=23036639
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL15759402A IL157594A0 (en) | 2001-02-27 | 2002-02-21 | Carbamate compounds for use in preventing or treating anxiety disorders |
Country Status (25)
| Country | Link |
|---|---|
| US (3) | US7078436B2 (de) |
| EP (1) | EP1399144B1 (de) |
| JP (1) | JP2004523554A (de) |
| KR (1) | KR20030078947A (de) |
| CN (1) | CN1503665A (de) |
| AT (1) | ATE324107T1 (de) |
| AU (1) | AU2002306567B2 (de) |
| BR (1) | BR0207830A (de) |
| CA (1) | CA2439286A1 (de) |
| CY (1) | CY1107468T1 (de) |
| CZ (1) | CZ20032311A3 (de) |
| DE (1) | DE60210960T2 (de) |
| DK (1) | DK1399144T3 (de) |
| ES (1) | ES2262826T3 (de) |
| HU (1) | HUP0303262A2 (de) |
| IL (1) | IL157594A0 (de) |
| MX (1) | MXPA03007720A (de) |
| MY (1) | MY136391A (de) |
| NO (1) | NO20033800L (de) |
| NZ (1) | NZ546549A (de) |
| PL (1) | PL364639A1 (de) |
| PT (1) | PT1399144E (de) |
| RS (1) | RS50505B (de) |
| RU (1) | RU2292881C2 (de) |
| WO (1) | WO2002067923A1 (de) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MXPA03007720A (es) * | 2001-02-27 | 2004-11-12 | Johnson & Johnson | Compuestos de carbamato para su uso en la prevencion o el tratamiento de transtornos de ansiedad. |
| JP2008528489A (ja) | 2005-01-20 | 2008-07-31 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | Ｑｔ間隔調節方法 |
| ES2435403T3 (es) | 2005-06-08 | 2013-12-19 | Sk Biopharmaceuticals Co., Ltd. | Tratamiento de trastornos del sueño y vigilia |
| JP2010508279A (ja) * | 2006-10-27 | 2010-03-18 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | 破壊的行動障害の処置法 |
| US8263652B2 (en) | 2007-10-31 | 2012-09-11 | Sk Biopharmaceuticals Co., Ltd. | Stabilized pediatric suspension of carisbamate |
| US8609849B1 (en) | 2010-11-30 | 2013-12-17 | Fox Chase Chemical Diversity Center, Inc. | Hydroxylated sulfamides exhibiting neuroprotective action and their method of use |
| ES2998534T3 (en) | 2013-03-12 | 2025-02-20 | Bio Pharm Solutions Co Ltd | Phenyl carbamate compounds for use in preventing or treating pediatric epilesy |
| US9907776B2 (en) | 2013-03-12 | 2018-03-06 | Bio-Pharm Solutions, Co., Ltd. | Phenyl carbamate compound and a composition for preventing or treating a psychiatric disorder comprising the same |
| JP6807941B2 (ja) * | 2016-02-29 | 2021-01-06 | バイオ−ファーム ソリューションズ カンパニー リミテッド | スルファメート誘導体化合物、その製造方法および用途 |
| US10195151B2 (en) | 2016-09-06 | 2019-02-05 | Jazz Pharmaceuticals International Iii Limited | Formulations of (R)-2-amino-3-phenylpropyl carbamate |
| KR102900173B1 (ko) * | 2016-12-14 | 2025-12-12 | 에스케이바이오팜 주식회사 | 조현병, 강박장애 및 투렛증후군으로부터 선택되는 정신증 장애의 예방, 경감 또는 치료에 있어서의 카바메이트 화합물의 용도 |
| AU2018278332B2 (en) | 2017-06-02 | 2022-05-19 | Jazz Pharmaceuticals Ireland Limited | Methods and compositions for treating excessive sleepiness |
| US10940133B1 (en) | 2020-03-19 | 2021-03-09 | Jazz Pharmaceuticals Ireland Limited | Methods of providing solriamfetol therapy to subjects with impaired renal function |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3313692A (en) | 1958-04-21 | 1967-04-11 | Armour Pharma | Method of inducing calming and muscle relaxation with carbamates |
| US3278380A (en) * | 1962-02-06 | 1966-10-11 | Armour Pharma | Methods of calming employing diphenyl hydroxy carbamate compounds |
| US3248418A (en) | 1962-06-26 | 1966-04-26 | Charles D Bossinger | 2-hydroxy-2-phenyl alkyl carbamates |
| US3265728A (en) * | 1962-07-18 | 1966-08-09 | Armour Pharma | Substituted phenethyl carbamates |
| CN1109880A (zh) * | 1994-02-03 | 1995-10-11 | 合成实验室公司 | 3-(2-氨基乙基)-4-[3-(三氟甲基)苯甲酰基]-3，4-二氢-2h-1，4-苯并噁嗪衍生物、制备及其应用 |
| US5698588A (en) * | 1996-01-16 | 1997-12-16 | Yukong Limited | Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol |
| CZ302412B6 (cs) | 2001-02-27 | 2011-05-04 | Ortho-Mcneil Pharmaceutical, Inc. | Lécivo pro prevenci nebo lécbu psychotických chorob |
| MXPA03007720A (es) * | 2001-02-27 | 2004-11-12 | Johnson & Johnson | Compuestos de carbamato para su uso en la prevencion o el tratamiento de transtornos de ansiedad. |
| CA2439475C (en) | 2001-02-27 | 2010-05-18 | Carlos R. Plata-Salaman | Carbamate compounds for use in preventing or treating bipolar disorder |
-
2002
- 2002-02-21 MX MXPA03007720A patent/MXPA03007720A/es active IP Right Grant
- 2002-02-21 KR KR10-2003-7011293A patent/KR20030078947A/ko not_active Ceased
- 2002-02-21 RS YUP-679/03A patent/RS50505B/sr unknown
- 2002-02-21 BR BR0207830-9A patent/BR0207830A/pt not_active IP Right Cessation
- 2002-02-21 PT PT02759750T patent/PT1399144E/pt unknown
- 2002-02-21 ES ES02759750T patent/ES2262826T3/es not_active Expired - Lifetime
- 2002-02-21 AT AT02759750T patent/ATE324107T1/de active
- 2002-02-21 PL PL02364639A patent/PL364639A1/xx not_active Application Discontinuation
- 2002-02-21 JP JP2002567290A patent/JP2004523554A/ja active Pending
- 2002-02-21 CA CA002439286A patent/CA2439286A1/en not_active Abandoned
- 2002-02-21 IL IL15759402A patent/IL157594A0/xx unknown
- 2002-02-21 US US10/081,713 patent/US7078436B2/en not_active Expired - Fee Related
- 2002-02-21 CN CNA028087143A patent/CN1503665A/zh active Pending
- 2002-02-21 NZ NZ546549A patent/NZ546549A/en not_active IP Right Cessation
- 2002-02-21 HU HU0303262A patent/HUP0303262A2/hu unknown
- 2002-02-21 RU RU2003128986/14A patent/RU2292881C2/ru not_active IP Right Cessation
- 2002-02-21 DE DE60210960T patent/DE60210960T2/de not_active Expired - Lifetime
- 2002-02-21 DK DK02759750T patent/DK1399144T3/da active
- 2002-02-21 EP EP02759750A patent/EP1399144B1/de not_active Expired - Lifetime
- 2002-02-21 WO PCT/US2002/005423 patent/WO2002067923A1/en not_active Ceased
- 2002-02-21 AU AU2002306567A patent/AU2002306567B2/en not_active Ceased
- 2002-02-21 CZ CZ20032311A patent/CZ20032311A3/cs unknown
- 2002-02-27 MY MYPI20020693A patent/MY136391A/en unknown
-
2003
- 2003-08-26 NO NO20033800A patent/NO20033800L/no not_active Application Discontinuation
-
2005
- 2005-08-01 US US11/194,251 patent/US20050267203A1/en not_active Abandoned
-
2006
- 2006-06-21 CY CY20061100843T patent/CY1107468T1/el unknown
-
2009
- 2009-06-01 US US12/475,815 patent/US20090234003A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CN1503665A (zh) | 2004-06-09 |
| CY1107468T1 (el) | 2012-12-19 |
| AU2002306567B2 (en) | 2006-08-17 |
| US20020143053A1 (en) | 2002-10-03 |
| US7078436B2 (en) | 2006-07-18 |
| PT1399144E (pt) | 2006-07-31 |
| DK1399144T3 (da) | 2006-07-24 |
| NZ546549A (en) | 2007-11-30 |
| EP1399144B1 (de) | 2006-04-26 |
| US20050267203A1 (en) | 2005-12-01 |
| BR0207830A (pt) | 2004-06-22 |
| PL364639A1 (en) | 2004-12-13 |
| HK1062270A1 (en) | 2004-10-29 |
| RS50505B (sr) | 2010-03-02 |
| US20090234003A1 (en) | 2009-09-17 |
| RU2292881C2 (ru) | 2007-02-10 |
| JP2004523554A (ja) | 2004-08-05 |
| NO20033800D0 (no) | 2003-08-26 |
| KR20030078947A (ko) | 2003-10-08 |
| MXPA03007720A (es) | 2004-11-12 |
| DE60210960D1 (de) | 2006-06-01 |
| NO20033800L (no) | 2003-09-26 |
| HUP0303262A2 (hu) | 2004-01-28 |
| ATE324107T1 (de) | 2006-05-15 |
| RU2003128986A (ru) | 2005-03-20 |
| CA2439286A1 (en) | 2002-09-06 |
| ES2262826T3 (es) | 2006-12-01 |
| DE60210960T2 (de) | 2006-11-16 |
| WO2002067923A1 (en) | 2002-09-06 |
| CZ20032311A3 (cs) | 2005-02-16 |
| EP1399144A1 (de) | 2004-03-24 |
| YU67903A (sh) | 2006-08-17 |
| MY136391A (en) | 2008-09-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| YU67703A (sh) | Karbamatna jedinjenja za upotrebu u sprečavanju ili lečenju poremećaja kretanja | |
| MY138156A (en) | Carbamate compounds for use in preventing or treating neurodegenerative disorders | |
| NO20071921L (no) | Fremgangsmater for behandling av epileptogenese og epilepsi | |
| MY133370A (en) | Carbamate compounds for use in preventing or treating bipolar disorders | |
| IL157590A0 (en) | Carbamate compounds for use in preventing or treating bipolar disorder | |
| IL157594A0 (en) | Carbamate compounds for use in preventing or treating anxiety disorders | |
| MY129312A (en) | Carbamate compounds for use in the treatment of pain | |
| AU7349301A (en) | Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain | |
| IL159847A0 (en) | Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain | |
| MY136733A (en) | Carbamate compounds for use in preventing or treating psychotic disorders | |
| MY136347A (en) | Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain | |
| PL368112A1 (en) | Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain | |
| MY137446A (en) | Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain |